Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1985]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Positive results in phase II study of copanlisib treating NHL and CLL
Dr George Follows - Cambridge University Hospitals NHS Foundation Trust...
Positive results in phase II study of copanlisib treating NHL and CLL ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
30 Apr 2015
Dual mTOR inhibition effective in reducing tumour load in CLL
Dr Emilio Cosimo - University of Glasgow, Glasgow, UK
Dual mTOR inhibition effective in reducing tumour load in CLL ( Dr Emilio Cosimo - University of Glasgow, Glasgow, UK )
30 Apr 2015
Putting the patient at the centre of cancer-associated thrombosis treatment...
Dr Simon Noble - Cardiff University, Cardiff, UK
Putting the patient at the centre of cancer-associated thrombosis treatment decisions ( Dr Simon Noble - Cardiff University, Cardiff, UK )
30 Apr 2015
Developing treatments for indolent non hodgkin lymphoma
Dr Andrew Davies and Dr Paul Fields
Developing treatments for indolent non hodgkin lymphoma ( Dr Andrew Davies and Dr Paul Fields )
29 Apr 2015
Latest trials and outcomes with new CLL treatments
Dr George Follows and Professor Peter Hillmen
Latest trials and outcomes with new CLL treatments ( Dr George Follows and Professor Peter Hillmen )
29 Apr 2015
Updated results on phase III CLL trial shows 90% response rate using ibrutinib
Dr Claire Dearden - Royal Marsden Hospital, London, UK
Updated results on phase III CLL trial shows 90% response rate using ibrutinib ( Dr Claire Dearden - Royal Marsden Hospital, London, UK )
29 Apr 2015
The evolution of CLL treatment
Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence...
The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista )
28 Apr 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant...
Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
27 Apr 2015
How to decide the treatment of CLL in 2015
Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015
New drugs and targets in haematological malignancies
Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA
New drugs and targets in haematological malignancies ( Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Mar 2015
ecancermedicalscience editor's choice for February 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for February 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
3 Mar 2015
ecancermedicalscience editor's choice for January 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for January 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
4 Feb 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation